D. Boullin

发表

Responses of human and baboon arteries to prostaglandin endoperoxides and biologically generated and synthetic prostacyclin: their relevance to cerebral arterial spasm in man.

S. Moncada, S. Bunting, D. Boullin, 1979, British journal of clinical pharmacology.

Responses of baboon cerebral and extracerebral arteries to prostacyclin and prostaglandin endoperoxide in vitro and in vivo.

G. du Boulay, B. Kendall, D. Boullin, 1979, Journal of neurology, neurosurgery, and psychiatry.

Vasoconstrictor activity in cerebrospinal fluid from patients subjected to early surgery for ruptured intracranial aneurysms.

P. Tagari, L. Brandt, B. Ljunggren, 1981, Journal of neurosurgery.

Effects of Intracranial Dopamine Perfusion: Behavioural Arousal and Reversal of Cerebral Arterial Spasm following Surgery for Clipping of Ruptured Cerebral Aneurysms

A. R. Green, A. Rogers, D. Boullin, 1977, Proceedings of the Royal Society of Medicine.

MODELS FOR INVESTIGATING THE AETIOLOGY OF CEREBRAL ARTERIAL SPASM: COMPARATIVE RESPONSES OF THE HUMAN BASILAR ARTERY WITH RAT COLON, ANOCOCCYGEUS, STOMACH FUNDUS, AND AORTA AND GUINEA‐PIG ILEUM AND COLON

A. Rogers, D. Boullin, T. M. Hunt, 1978, British journal of pharmacology.

Vasoconstrictor and vasodilator effects of leukotriene D4 and FPL 55712 on human and rat cerebral arteries.

G. du Boulay, P. Tagari, D. Boullin, 1983, Advances in prostaglandin, thromboxane, and leukotriene research.

Pharmacological Vasoconstrictor Activity of Cerebrospinal Fluid

D. Boullin, W. P. Blaso, 1983 .

Monoamine metabolism and platelet function in iron-deficiency anaemia.

H. Woods, M. Youdim, D. Boullin, 1976, Ciba Foundation symposium.

Single and repeated administration of neuroleptic drugs to rats: Effects on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and L-tryptophan or L-dopa

A. R. Green, D. Heal, D. Boullin, 1976, Psychopharmacology.

Intestinal absorption of dipeptides containing glycine, phenylalanine, proline, beta-alanine or histidine in the rat.

D. Boullin, D. Pelling, R. Crampton, 1973, Clinical science and molecular medicine.

E. INTERACTIONS OF DRUGS WITH ADRENERGIC NEURONS

B. Brodie, W. Vogel, D. Boullin, 1966 .

Interactions of drugs with adrenergic neurons.

B. Brodie, W. Vogel, D. Boullin, 1966, Pharmacological reviews.

Pharmacological responses of thiamine-deficient rat tissues.

D. Boullin, 1963, British journal of pharmacology and chemotherapy.

CSF smooth-muscle constrictor activity associated with cerebral vasospasm and mortality in SAH patients.

A. Kaye, P. Tagari, P. Teddy, 1984, Journal of Neurosurgery.

The role of hemoglobin in the etiology of cerebral vasospasm. An in vivo study of baboons.

G. du Boulay, P. Tagari, J. Hughes, 1983, Journal of neurosurgery.

The 5-hydroxytryptamine antagonist ketanserin inhibits the vasoconstrictor activity of per-operative CSF, from subarachnoid haemorrhage patients, on isolated tissues.

A. Kaye, P. Tagari, P. Teddy, 1983, Journal of neurology, neurosurgery, and psychiatry.

Relationship between presence of vasoconstrictor activity in cerebrospinal fluid and time after subarachnoid haemorrhage from rupture of cerebral arterial aneurysms.

G. du Boulay, D. Forster, D. Boullin, 1979, Journal of neurology, neurosurgery, and psychiatry.

Evidence for the presence of a vasoactive substance (possibly involved in the aetiology of cerebral arterial spasm) in cerebrospinal fluid from patients with subarachnoid haemorrhage.

D. Boullin, D. Grahame-Smith, J. Mohan, 1976, Journal of neurology, neurosurgery, and psychiatry.

Responses of isolated human basilar arteries to 5-hydroxytryptamine, noradrenaline, serum, platelets, and erythrocytes.

C. Adams, D. Boullin, D. Grahame-Smith, 1975, Journal of neurology, neurosurgery, and psychiatry.

Evidence that blockade of adrenergic receptors causes overflow of norepinephrine in cats colon after nerve stimulation.

B. Brodie, D. Boullin, E. Costa, 1967, The Journal of pharmacology and experimental therapeutics.

Aetiology of cerebral arterial spasm following subarachnoid haemorrhage: evidence against a major involvement of 5-hydroxy-tryptamine in the production of acute spasm.

G. du Boulay, A. Rogers, D. Boullin, 1978, British journal of clinical pharmacology.

Effects of aspirin and prostaglandin E2 on secondary phase aggregation responses of schizophrenic patients treated with chlorpromazine.

D. Boullin, M. Orr, 1976, British journal of clinical pharmacology.

Abnormalities of 5‐hydroxytryptamine uptake and binding by blood platelets from children with Down's syndrome

R. O'brien, D. Boullin, 1971, The Journal of physiology.

Simplified determination of serotonin in plasma by liquid chromatography with electrochemical detection.

C. L. Davies, P. Tagari, D. Boullin, 1984, Clinical chemistry.

Leukotriene D4 and the cerebral vasculature in vivo and in vitro.

G. du Boulay, P. Tagari, D. Boullin, 1983, Prostaglandins, leukotrienes, and medicine.

Mechanisms by which human blood platelets accumulate glycine, gaba and amino acid precursors of putative neurotransmitters

A. R. Green, D. Boullin, A. Green, 1972, British journal of pharmacology.

Pharmacological Vasoconstrictor Activity of Cerebrospinal Fluid Relationship to Arterial Caliber and Clinical yasospasm after Subarachnoid Hemorrhage and Aneurysm Surgery

D. Boullin, W. P. Blaso, 1983 .

The ralationship between changes in 5-HT induced platelet aggregation and clinical state in patients treated with fluphenazine.

D. Boullin, M. Orr, 1976, British journal of clinical pharmacology.

Platelet aggregation and chlorpromazine therapy.

J. Peters, D. Boullin, M. Gelder, 1978, British journal of clinical pharmacology.

Increased platelet aggregation responses to 5-hydroxytryptamine in patients taking chlorpromazine.

H. Woods, D. Boullin, D. Grahame-Smith, 1975, British journal of clinical pharmacology.

INHIBITION OF 5‐HYDROXYTRYPTAMINE‐INDUCED HUMAN BLOOD PLATELET AGGREGATION BY CHLORPROMAZINE AND ITS METABOLITES

H. Woods, D. Boullin, D. Grahame-Smith, 1975, British journal of pharmacology.

Towards the resolution of conflicting findings

M. Rutter, B. Freeman, E. Ritvo, 1982 .

Accumulation, storage and release of adrenergic neuron blocking agents and related drugs by human platelets.

R. O'brien, D. Boullin, 1972, Biochemical pharmacology.

Uptake and loss of14C-dopamine by platelets from children with infantile autism

R. O'brien, D. Boullin, 1972, Journal of autism and childhood schizophrenia.

Accumulation of dopamine by blood platelets from normal subjects and parkinsonian patients under treatment with l‐DOPA

R. O'brien, D. Boullin, 1970, British journal of pharmacology.

CHARACTERIZATION OF RECEPTORS MEDIATING 5‐HYDROXYTRYPTAMINE‐ AND CATECHOLAMINE‐INDUCED PLATELET AGGREGATION, ASSESSED BY THE ACTIONS OF α‐ AND β‐BLOCKERS, BUTYROPHENONES, 5‐HT ANTAGONISTS AND CHLORPROMAZINE

P. Glenton, D. Boullin, DJ. BOULLIN, 1978, British journal of pharmacology.

The action of extracellular cations on the release of the sympathetic transmitter from peripheral nerves

D. Boullin, 1967, The Journal of physiology.

Reduction of C-guanethidine levels in rat heart and diaphragm by excess calcium.

D. Boullin, 1966, British journal of pharmacology and chemotherapy.

The accumulation of guanethidine by human blood platelets

R. O'brien, D. Boullin, D. J. BOULLIN, 1969, British journal of pharmacology.

Blood Platelets as a Model for Brain Neurones: Relevance to Psychiatric Disorders and Mental Abnormalities

D. Boullin, 1979 .

TRANSPORT OF TAURINE BY NORMAL HUMAN BLOOD PLATELETS

D. Boullin, M. Paasonen, L. Ahtee, 1974, British journal of pharmacology.

Can the human blood platelet be used as a model for the cholinergic nerve ending

I. Hanin, D. Boullin, R. Massarelli, 1972 .

Platelet shape change in patients with psychiatric disorders and treated with phenothiazines, thioxanthines, butyrophenones, benzodiazepines, tricyclic antidepressants and ß-adrenergic blocking agents

D. Boullin, 2005, Journal of Neural Transmission.

THE BINDING OF HALOPERIDOL TO HUMAN BLOOD PLATELETS AND INTERACTIONS WITH 5‐HYDROXYTRYPTAMINE AND DOPAMINE

D. Molyneux, D. Boullin, B. Roach, 1978, British journal of pharmacology.

807 – BLOOD PLATELETS AS A MODEL FOR THE ACTIONS OF PSYCHOTROPIC DRUGS ON CENTRAL SEROTONINERGIC NEURONES

J. Peters, P. Glenton, D. Boullin, 1978 .

Increased platelet aggregation in patients receiving chlorpromazine: responses to 5-hydroxytryptamine, dopamine and N-dimethyl dopamine.

D. Boullin, R. Grimes, 1976, British journal of clinical pharmacology.

Studies of Platelet Aggregation in Diabetic Coma

R. D. Simpson, T. Hockaday, D. Boullin, 1975 .

The metabolism of 5-hydroxytryptamine by blood platelets from children with mongolism.

R. O'brien, D. Boullin, 1973, Biochemical pharmacology.

The mechanism of adenosine diphosphate induced platelet aggregation: binding to platelet receptors and inhibition of binding and aggregation by prostaglandin E1

D. Boullin, A. Green, K. S. Price, 1972, The Journal of physiology.

The calibre of cerebral arteries of the rat studied by carotid angiography: A model system for studying the aetiology of human cerebral arterial constriction after aneurysmal rupture

P. Tagari, D. Boullin, G. Boulay, 2005, Neuroradiology.

Specificity of action of 6-hydroxydopamine in peripheral cat tissues: depletion of noradrenaline without depletion of 5-hydroxytryptamine.

D. Boullin, E. Costa, M. Votavová, 1971, Life sciences. Pt. 1: Physiology and pharmacology.

THE ACTION OF TRIETHYLCHOLINE ON THE PERISTALTIC REFLEX OF THE GUINEA-PIG ILEUM.

D. Boullin, 1963, British journal of pharmacology and chemotherapy.

A calcium requirement for release of 3H‐guanethidine by sympathetic nerve stimulation

D. Boullin, 1966, The Journal of pharmacy and pharmacology.

OBSERVATIONS ON THE SIGNIFICANCE OF 5-HYDROXYTRYPTAMINE IN RELATION TO THE PERISTALTIC REFLEX OF THE RAT.

D. Boullin, 1964, British journal of pharmacology and chemotherapy.

Behaviour of rats depleted of 5-hydroxytryptamine by feeding a diet free of tryptophan

D. Boullin, 1963, Psychopharmacologia.

Laboratory predictions of infantile autism based on 5-hydroxytryptamine efflux from blood platelets and their correlation with the rimland E-2 score

R. O'brien, B. Rimland, M. Coleman, 1971, Journal of autism and childhood schizophrenia.

Abnormalities in Platelet 5-Hydroxytryptamine Efflux in Patients with Infantile Autism

R. O'brien, M. Coleman, D. Boullin, 1970, Nature.

The binding of imipramine to the outer membrane of blood platelets

R. O'brien, D. Boullin, 1968, The Journal of pharmacy and pharmacology.

GARLIC AS A PLATELET INHIBITOR

D. Boullin, 1981, The Lancet.

EFFECT OF PYRIDOXINE DEFICIENCY ON INTESTINAL HISTAMINASE IN THE RAT.

D. Boullin, A. Abdel-Aziz, 1964, Biochemical pharmacology.

Thiamine requirement of rats given a high-protein, carbohydrate-free diet

D. Boullin, 1961, British Journal of Nutrition.

Effect of deoxypyridoxine on signs of pyridoxine deficiency and intestinal 5-hydroxytryptamine

D. Boullin, 1964, British Journal of Nutrition.

Resuspension of platelets: enhanced 5-hydroxytryptamine-induced aggregation in chlorpromazine treated patients due to changes in platelet properties.

H. Woods, D. Boullin, D. Grahame-Smith, 1975, British Journal of Clinical Pharmacology.

Discharge of tritium-labeled guanethidine by sympathetic nerve stimulation as evidence that guanethidine is a false transmitter

E. Costa, B. Brodie, D. Boullin, 1966 .

Platelet monoamine oxidase in children with infantile autism.

R. O'brien, M. Coleman, H. Bhagavan, 1975, Medical biology.

Constriction of cerebral arteries by angiotensin

D. Boullin, G. Boulay, V. Aitken, 1980 .

Defective binding of 5-HT by blood platelets from children with the trisomy 21 form of Down's syndrome.

R. O'brien, M. Coleman, D. Boullin, 1969, The Journal of physiology.

Parachlorophenylalanine administration to a retarded patient with high blood serotonin levels.

M. Coleman, A. Barnet, D. Boullin, 1970, Transactions of the American Neurological Association.

Spinal trauma: pharmacological evidence for vasoconstrictor activity in cerebrospinal fluid.

P. Tagari, J. Hughes, D. Boullin, 1981, Journal of neurology, neurosurgery, and psychiatry.

Short report Spinal trauma : pharmacological evidence for vascoconstrictor activity in cerebrospinal fluid

P. Tagari, J. Hughes, D. Boullin, 2022 .

Nutrition and drug actions and interactions.

D. Boullin, 1977, Primary Care.

AN ICONOGRAPHIC STUDY OF SANDGLASSES

D. Boullin, 1989 .

THE ACTIONS OF FLUPENTHIXOL UPON 5‐HYDROXYTRYPTAMINE‐INDUCED AGGREGATION AND THE UPTAKE OF 5‐HYDROXYTRYPTAMINE AND DOPAMINE BY HUMAN BLOOD PLATELETS

D. Boullin, M. Orr, R. Grimes, 1975, British journal of pharmacology.

Accumulation of quinidine by human blood platelets: effects on platelet ultrastructure and 5‐hydroxytryptamine

R. O'brien, D. Boullin, D. J. BOULLIN, 1971, British journal of pharmacology.

Relationship between the uptake, binding and pharmacological action of procaine in the isolated heart

D. Boullin, T. J. Sullivan, D. J. BOULLIN, 1969, British journal of pharmacology.

Evidence for intra-cellular guanethidine stores in the fat heart revealed after removal of calcium ions.

D. Boullin, 1968, British journal of pharmacology and chemotherapy.

Uptake of debrisoquin and guanethidine by human blood platelets

R. O'brien, D. Boullin, D. J. Boullin, 1968, The Journal of pharmacy and pharmacology.

The inhibition of the uptake of monoamines by blood platelets by phenothiazines and other drugs.

D. Boullin, L. Saarnivaara, L. Ahtee, 1974, Advances in biochemical psychopharmacology.

Effects of (+) and (-)-propranolol on the responses of the human isolated basilar artery to cerebrospinal fluid obtained from patients with subarachnoid haemorrhage and cerebral arterial spasm.

D. Boullin, J. Mohan, 1977, British journal of clinical pharmacology.

Serotonin in mental abnormalities

D. Boullin, 1978 .

Binding of 5-hydroxytryptamine to human blood platelets [proceedings].

J. Peters, D. Molyneux, P. Glenton, 1977, British journal of pharmacology.